date:Nov 22, 2012
BASF has announced that it plans to acquire Pronova BioPharma of Norway, a company with expertise in the research, development,and manufacturing of omega-3 fatty acids.
BASF has reached an agreement with Pronova to make a recommended voluntary public takeover offer to Pronovas shareholders, and will offer to pay NOK12.50 in cash for each Pronova share, valuing the acquisition at NOK4,845 million/ 664 million.
The offer corresponds to a premium of 24% above the volume-weighted average share pri